SMARTMEDICINE

Marketer for Otsuka

Iclusig

ponatinib

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EA05 - ponatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in